Vaccine hesitancy is not simply an information deficit problem — it is a psychological, social, and structural phenomenon that traditional fact-based messaging largely fails to address. For pediatric immunization programs, where parental trust is the decisive variable, this distinction carries real consequences for child health outcomes across entire communities.
This review, published in Expert Review of Vaccines, examines the architecture of vaccine hesitancy specifically within pediatric populations, with a lens on Latin America where health system fragmentation compounds the challenge. The authors evaluate two communication frameworks gaining traction in public health research: narrative shielding, which uses story-based messaging to build cognitive and emotional resistance to misinformation before it takes hold, and prebunking, a form of anticipatory inoculation that exposes caregivers to weakened forms of misleading arguments alongside explicit refutation. The review draws on peer-reviewed literature and global health reports, though it is a targeted rather than systematic review, which limits the precision of its evidence grading. The authors argue these strategies may complement — not replace — conventional trust-building and structural interventions.
What makes this analysis particularly relevant is the growing body of psychological inoculation research, pioneered in part by work from groups like the Cambridge Social Decision-Making Lab, which has demonstrated measurable reductions in susceptibility to health misinformation through brief prebunking interventions. The application to pediatric immunization contexts, especially in resource-variable Latin American settings, is an under-studied frontier. This review is largely synthesizing rather than generating new empirical data, and the practical implementation of narrative-based strategies at scale remains poorly evaluated. Still, the framework represents a meaningful conceptual advance: treating hesitancy as a persuasion problem requiring prophylactic communication, not merely corrective messaging delivered after resistance has already formed. For clinicians, the implication is that the conversation about vaccines should begin before doubt arrives.